Results 171 to 180 of about 3,538,014 (404)

International scoring system for evaluating prognosis in myelodysplastic syndromes.

open access: yesBlood, 1997
P. Greenberg   +14 more
semanticscholar   +1 more source

EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines

open access: yesMolecular Oncology, EarlyView.
The Parsortix® system was tested for CTC enrichment using pancreatic cancer cell lines with different EMT phenotypes. Spike‐in experiments showed lower recovery of mesenchymal‐like cells. This was confirmed with an EMT‐inducible breast cancer cell line.
Nele Vandenbussche   +8 more
wiley   +1 more source

Genomic Classification and Prognosis in Acute Myeloid Leukemia.

open access: yesNew England Journal of Medicine, 2016
E. Papaemmanuil   +26 more
semanticscholar   +1 more source

A DIA‐MS‐based proteomics approach to find potential serum prognostic biomarkers in glioblastoma patients

open access: yesMolecular Oncology, EarlyView.
A DIA‐MS‐based proteomics analysis of serum samples from GB patients and healthy controls showed that high levels of IL1R2 and low levels of CRTAC1 and HRG in serum are associated with poor survival outcomes for GB patients. These circulating proteins could serve as biomarkers for the prediction of outcome in patients with GB.
Anne Clavreul   +11 more
wiley   +1 more source

Prognosis [PDF]

open access: yesOtolaryngology–Head and Neck Surgery, 2013
openaire   +2 more sources

Home - About - Disclaimer - Privacy